News | November 09, 2021
Wockhardt PAT at Rs 33.53 cr. in Q2FY22
The Board of Directors of Wockhardt have approved the unaudited consolidated financial results for the period ended September 30, 2021.
The Board of Directors of Wockhardt have approved the unaudited consolidated financial results for the period ended September 30, 2021.
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Lyka Labs has reported consolidated financial results for the period ended September 30, 2021
The company is a medical dictation solution used by medical practitioners
The combined entity will have 12 hospitals with 3,666 beds
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
_1_256_384.png)
Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
Subscribe To Our Newsletter & Stay Updated
